Aim: There are increasing cases of rhino-orbital mucormycosis in patients who found positive for corona virus (COVID-19). Diabetes Mellitus (DM) is main risk factor for both COVID-19 and mucormycosis. We aim to find out ocular manifestation of mucormycosis in post COVID patients.
Material and methods: we conducted a study in 110 patients at Dr. S.N. medical college, Jodhpur, Rajasthan. We selected all the details of case reports/series of patients with mucormycosis and COVID-19 who came to OPD during COVID pandemic with chief complain of upper respiratory tract infection like fever, cold, cough. Then, we analyzed the patients according to associated co-morbidities, location of mucormycosis, use of steroids and ocular complaints of mucormycosis.
Results: we selected 110 patients for the study who found positive for COVID-19 at any time during or before the study. In this study 82 patients (74.54%) were males and 28 were females, both in patients who were active for COVID-19 64 patients (58%) and recovered 46 patients (42%). Pre-existing DM was present in 81 patients (73.63%); Diabetic Ketoacidosis (DKA) was present in 15 patients (13.63%). History of corticosteroid uses for COVID-19 treatment was present in 78 patients (70.90%); history of remdesivir for COVID-19 treatment was present in 12 patients (29.10%). History of no steroid was present in 20 patients. Most common sign found is ptosis in 60 patients (54.54%), total ophthalmoplagia in 58 patients (52.72%), proptosis in 58 patients (52.72%), periocular edema in 57 patients (51.81%), periocular tenderness in 57 patients (51.81%), decreased vision noted in 15 patients (13.63%), in which complete loss of vision in 10 patients (9.09%), central retinal artery occlusion is found in 10 patients (9.09%), disc pallor is found in 10 patients (9.09%).
Conclusion: Diabetes is important risk factor both COVID-19 and mucormyosis.
Select your language of interest to view the total content in your interested language